Jashvik Capital expands medtech platform with Rivarp Medical investment
MUMBAI: Private equity firm Jashvik Capital on Tuesday said it has expanded its medical devices platform with portfolio company Futura Medtech, which has invested in Bengaluru-based Rivarp Medical, making its third investment through the platform.
Rivarp Medical manufactures devices and implants in orthopedics, neurosurgery and interventional cardiology, and Jashvik is adding new therapeutic segments to Futura as it builds a scaled, multi-category medical devices business with local and global reach, the companies said in a joint statement.
The platform invested in Dolphin Sutures in October 2024 and Suture Planet in July 2025. Jashvik Capital invested in Bengaluru-based surgical consumables and devices manufacturer Futura in June 2024.
Naresh Patwari, founder of Jashvik Capital, said: “Medical devices and consumables are a large and fast-growing opportunity in India and international markets. Our management team aims to leverage synergies related to innovation, manufacturing, sales and distribution channels through these acquisitions.” Mint.
The company did not disclose the financial terms of the deal.
“Partnering with Futura Medtech gives us access to capital to invest in innovation and deepen customer engagement. Futura has deep distribution across various channels that complements Rivarp’s distribution strength,” MT Naidu, founder of Rivarp, said in a statement.
Differentiated portfolio
Founded in 2016, Rivarp Medical has developed a portfolio of products in fast-growing therapeutic segments. It has in-house manufacturing capacity and international regulatory approvals, including EU MDR and US FDA certifications.
The company distributes its products across India and international markets through a network of over 100 channel partners.
India’s medical devices sector is witnessing sustained double-digit growth, driven by increasing healthcare penetration, shift towards domestic manufacturing and expanding export opportunities. In this framework, Futura Medtech is being developed as an integrated platform combining product innovation, production scale and distribution reach.
“We plan to invest in more businesses over the next two years to further strengthen our product basket and innovation pipeline and deepen our distribution reach,” Patwari said.
Jashvik Capital invested $25 million in Futura in 2024. According to the company, the capital is being used to manufacture devices and consumables across multiple specialties, drive organic and inorganic growth, and expand access to high-quality medical products in India and international markets.
Mid-sized private equity firm had previously invested ₹400 crore in pharma software provider Marg ERP in July 2025. It has also invested in Bharuch-based Jabsons Foods and Hyderabad-based eye care chain Smart Vision Eye Specialties Pvt Ltd.
